Lyra Therapeutics (LYRA) Reiterated at Outperform by William Blair, Company Poised to Become a Major Player, Significant Disconnect in Valuation Exists, Remains Favorite Small-Cap Name,
Go back to Lyra Therapeutics (LYRA) Reiterated at Outperform by William Blair, Company Poised to Become a Major Player, Significant Disconnect in Valuation Exists, Remains Favorite Small-Cap Name,| (NASDAQ: LYRA) | Delayed: 0.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $ | |||
| Open | $0.50 | 52 Week Low | $ | |||
| Day High | $0.50 | P/E | N/A | |||
| Day Low | $0.50 | EPS | $ | |||
| Volume | 621 | |||||
